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In developing countries, hospitalized burn victims are at high risk of nosocomial infections
caused by Staphylococcus aureus. Risk factors include poor infection control practices, pro-
longed hospitalisation and limited capacity for laboratory microbiological analyses. These
problems are compounded by widespread use of antibiotics that drives the spread of multi-
drug resistant bacteria.
Methods
During the study period (November 2014-June 2015), nasal and invasive S. aureus isolates
were collected consecutively from patients and healthcare workers (HCWs) within the burn
unit of the Reconstructive Plastic Surgery and Burn Center of Korle Bu Teaching Hospital in
Ghana. Antibiotic prescription, antibiotic susceptibility and bacterial typing were used to
assess antibiotic pressure, antibiotic resistance, and possible transmission events among
patients and HCWs.
Results
Eighty S. aureus isolates were obtained from 37 of the 62 included burn patients and 13 of
the 29 HCWs. At admission, 50% of patients carried or were infected with S. aureus includ-
ing methicillin resistant S. aureus (MRSA). Antibiotic use per 100 days of hospitalization
was high (91.2 days), indicating high selective pressure for resistant pathogens. MRSA iso-
lates obtained from 11 patients and one HCW belonged to the same spa-type t928 and
multi-locus sequence type 250, implying possible transmission events. A mortality rate of
24% was recorded over the time of admission in the burn unit.
Conclusion
This study revealed a high potential for MRSA outbreaks and emergence of resistant patho-
gens amongst burn patients due to lack of patient screening and extended empirical use of
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antibiotics. Our observations underscore the need to implement a system of antibiotic stew-
ardship and infection prevention where microbiological diagnostics results are made avail-
able to physicians for timely and appropriate patient treatment.
Introduction
Burns are a major public health problem globally, but this problem is especially grave in low-
and middle-income countries (LMIC). Burns in LMIC lead to high mortality rates of over 95%
and the survivors frequently suffer from life long disabilities [1].
In sub-Saharan Africa, prevention and management of burns receive limited attention. The
general public lacks knowledge on prevention and first aid [2,3], and 84% of burns occur in
children below the age of ten years [4]. The few burn units available are frequently inade-
quately equipped and lack the needed multidisciplinary approach, including infection control
programs [5–8]. Burns in sub-Saharan Africa are often related to the use of petroleum prod-
ucts, leading to an equal ratio of scalds to flame burns [4,9]. This is exemplified by a petroleum
fire disaster in Ghana in 2015, which claimed about 200 lives in the southeastern part of the
country (daily graphic, 2nd June 2015). Reliable data on burn victims’ mortality is difficult to
obtain since people may die on the spot or when discharged from the hospital, and mortality
rates cannot be interpreted without data on the Total Body Surface Affected (TBSA). A recent
study, described a mortality rate of 13% in the burn patients who visited a university hospital
in the middle part of Ghana [10].
Infections are common in burn patients and, in particular, invasive infections are responsi-
ble for 28–65% of burn deaths worldwide [11,12]. Staphylococcus aureus is an opportunistic
pathogen that causes skin and soft tissue infections as well as invasive infection in burn
patients. In a South African intensive care burn unit, methicillin resistant S. aureus (MRSA)
was the third most common organism encountered in blood cultures. In this setting 17% of
the patients with MRSA-positive blood cultures died [13]. In addition, invasive infections
caused by Acinetobacter baumannii and Pseudomonas aeruginosa were found to frequently
lead to death of burn patients.
Recently, studies on S. aureus genetic diversity in healthcare and community settings have
detected spa-types t084, t314 and t355 to be predominant in Ghana [14–18]. However, there
has so far been no data published on the prevalence of S. aureus and this pathogen’s association
with invasive infections in burn centers in Ghana. The present study was therefore aimed at
assessing the epidemiology of S. aureus in burn patients in the Reconstructive Plastic Surgery
and Burn Center of the Korle Bu Teaching Hospital (KBTH), Korle Bu, Ghana, during a
seven-month survey. Burn patients and healthcare workers (HCWs) were screened for S.
aureus, and the antibiotic resistance profiles of nasal or invasive S. aureus isolates were investi-
gated. Data from this study is intended to guide future antimicrobial therapy and effective hos-
pital infection control.
Materials and methods
The burn unit of the Reconstructive Plastic Surgery and Burn Center of KBTH records about
328 admissions per year with about 27% in-hospital mortality. All burn patients are referred
from either the intensive care unit (ICU) of the hospital or from other regional or district hos-
pitals in the country. Patients are referred based on the severity of the burns, the surgical inter-
vention needed, and sometimes for logistical reasons. The burn unit comprises six beds each
in the adult male and female wards, seven beds in the children’s ward and two beds in the
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isolation ward. The unit has an operating theater and a treatment/dressing room. Wounds of
burn patients are cleaned with water containing antiseptic solution (cetrimide 3% w/v and
chlorhexidine gluconate 0.3% w/v). The wounds are subsequently rinsed with normal saline
and topical ointments containing antiseptics. Silver sulphadiazine and sulphadiazine are
applied onto the burn wound. This is followed by an occlusive dressing with paraffin-soaked
gauze, sterile cotton and a bandage. The dressings are changed every 72 hours.
Study participants
Following ethical clearance from the ethics committee of the Noguchi Memorial Institute for
Medical Research (FEDERAL WIDE ASSURANCE FWA 00001824), patients’ and HCWs
data and samples were collected for the present study. All samples were collected upon written
informed consent or assent from all participants aged12 years, and consent from a parent,
caretaker, or legal representative of any participant below the age of 18 years.
All patients consecutively admitted to the burn unit of the Reconstructive Plastic Surgery
and Burn Center of KBTH, Ghana, from November 2014 to May 2015 were invited to partici-
pate. General patient information including age, gender, type of injury, length of stay, outcome
(death or discharge), TBSA and use of antibiotics were retrieved from the patients’ files. How-
ever, patients’ data from the referral centers prior to admission in this burn unit was unavail-
able. Antibiotic consumption was expressed as the total number of days of antimicrobial use
per total number of admission days.
Specifically, both nares and wounds were swabbed using dry eSwabs, which were subse-
quently suspended in 1 ml liquid Amies medium (Copan Diagnostics Inc., Murrieta, CA,
USA). Blood cultures were collected from the patients upon admission in the burn unit and
biweekly during the change of wound dressings. Blood cultures testing positive for S. aureus,
or MRSA carriage were reported to the responsible clinician to ensure appropriate clinical
management. Nasal swabs were collected from healthcare workers once per two months for
the duration of the seven months study period.
Bacterial isolation, identification, mecA detection and antimicrobial
susceptibility testing
All swabs were streaked on 5% sheep blood agar (BA) and the respective plates were incubated
at 37˚C overnight. Presumptive S. aureus colonies were tested for coagulase using the Pastorex
Staph Plus test (Bio-rad, Marnes-la-Coquette, France) and nuc PCR [19]. S. aureus isolates
were confirmed using matrix-assisted laser desorption ionization-time of flight mass spec-
trometry (MALDI-TOF MS) with a microflex LT Biotyper (Bruker Daltonics, Bremen, Ger-
many) according to manufacturer’s instructions.
Blood cultures collected biweekly from patients were incubated in the BACTEC-9240 blood
culture system (Becton Dickinson, Sparks, MD, USA) for seven days. Cultures were made
from blood samples that gave positive signals for identification of S. aureus as described previ-
ously. To identify MRSA, all S. aureus isolates were screened for mecA gene as previously
described [20]. Antimicrobial susceptibility testing of S. aureus was initially performed using
the disk diffusion method on Muller Hinton Agar and interpreted according to the CLSI
guidelines at Noguchi Memorial Institute for Medical Research in Ghana [21]. These analyses
were, however, only performed on the S. aureus isolates from the nares and wounds of patients
and/or HCWs that tested positive for the mecA gene, and for the methicillin sensitive S. aureus
(MSSA) and MRSA isolates from invasive infections. Antimicrobial susceptibility testing was
further performed on all S. aureus isolates with the VITEK 2 system (AST-P633, bioMerieux
Corporate, Marcy l’Etoile, France) according to the manufacturer’s instructions at the
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diagnostics laboratory of the University Medical Center Groningen in the Netherlands. The
used cards contained the following antibiotics: benzylpenicillin, cefoxitin, chloramphenicol,
ciprofloxacin, clindamycin, erythromycin, fosfomycin, fusidic acid, gentamicin, kanamycin,
linezolid, mupirocin, oxacillin, rifampicin, teicoplanin, tetracycline, tobramycin, trimetho-
prim/sulfamethoxazole and vancomycin. The minimum inhibitory concentration results were
interpreted according to EUCAST guidelines (www.eucast.org).
Detection of the Panton-Valentine leukocidin genes and bacterial typing
All S. aureus isolates were screened for the presence of Panton Valentine Leucocidin (PVL) by
PCR as previously described [22]. Spa-typing of S. aureus isolates was performed as previously
described by Harmsen et al. [23]. DNA sequences were determined using an ABI Prism 3130
genetic analyser (Applied Biosystems, Foster City, USA). Spa-types were assigned using the
Ridom Staph Type software version 2.2.1 (Ridom GmbH, Wu¨rzburg, Germany) [23]. Multilo-
cus Sequence Typing (MLST) was performed on a subset of isolates (n = 70) as described by
Enright et al. [24].
Statistical analysis
Descriptive statistics including median and inter-quartile range (25–75%) were used for quan-
titative data (age, TBSA of the burn injury, and length of hospital stay). The association
between patients’ characteristics and the carriage of S. aureus was calculated using Pearson
chi-square or Fisher’s exact test and Mann-Whitney U test as appropriate. Statistical analysis
was performed with SPSS 22.0 (SPSS Inc., Chicago, IL) software.
Results
Patient characteristics
Sixty-seven patients were admitted to the burn unit during the study period. Sixty-two patients
were recruited while five patients declined participation. The patients were referred from 20
hospitals (n = 26) in Ghana and the ICU of the KBTH (n = 36). General patient characteristics
are presented in Table 1. The median age was 25 years (IQR: 3–35) and 36% of the participants
were younger than 10 years. Flames accounted for the cause of burns for the majority of the
patients. The median TBSA of the burn was 15% (IQR: 7.8–28.2%).
Table 1. Patient characteristics.
Patient characteristics Number (IQR or % frequency)
Sex (female, percentage) 37 (60%)







Scald (hot fluids) 18 (29%)
TBSA (median %) 15 (7.8–28.2)
Hospital stay (days)* 11 (5–17.5)
In-hospital mortality 15 (24.2%)
*Hospital stay refers exclusively to hospitalization in the burn unit
https://doi.org/10.1371/journal.pone.0181072.t001
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Twenty-nine HCWs (resident (n = 1), house officer (n = 1), nurses (n = 30) and cleaners
(n = 2)) were included during the study period. Twenty-four HCWs completed the study; the
other HCWs were transferred to other units within the hospital. Twenty-nine HCWs were
swabbed on each occasion including newly transferred HCWs. None of the HCWs declined
participation during the study.
S. aureus epidemiology in the burn unit
Eighty S. aureus isolates were obtained from 37 (60%) of the 62 patients and 13 (45%) of the 29
HCWs. Twenty-two (28%) isolates tested positive for the mecA gene. On the first day of admis-
sion (within 24 hours) 31 (50%) patients carried at least one S. aureus strain in their nares
(n = 21), burn wounds (n = 17), or both (n = 9). Four patients had S. aureus detected in their
blood culture. Two of these patients carried S. aureus in their nares and burn wounds simulta-
neously. Seven (11%) of the 62 patients tested MRSA-positive on the first day of admission,
two of whom had MRSA detected in their blood cultures. Four of these seven MRSA-positive
patients were referred from the KBTH ICU and three from one of the other referral centers. In
eight (13%) of the 62 patients S. aureus was cultured after the admission. These eight patients
carried at least one strain in their nares (n = 5), burn wounds (n = 5) or both (n = 3). In five of
these eight patients the acquired S. aureus strain was MRSA.
Thirteen (45%) of the 29 HCWs tested positive at least once with S. aureus during the study
period. One of the HCWs carried MRSA.
Antibiotic prescription and S. aureus resistance pattern
Cefuroxime was one of the antibiotics frequently consumed by burn patients. Further use of
antimicrobials was triggered by clinical events (fever or suspected sepsis) or—in a minority of
cases—by the detection of S. aureus invasive infections and sometimes MRSA wound coloniza-
tion during the current study. The antibiotics prescribed in the burn unit during the study
period are presented in Table 2.
All 80 S. aureus isolates were tested for susceptibility to antibiotics. The results are presented
in Table 2. None of the isolates were resistant to fosfomycin, fusidic acid, linezolid, mupirocin,
teicoplanin, or vancomycin. On the other hand, all isolates were resistant to benzylpenicillin
and over half of the isolates (51%) were resistant to tetracycline. Twenty-two (28%) isolates
were resistant to cefoxitin and oxacillin, and 21 of these isolates from 11 patients and one
HCW displayed a similar antibiotic resistance pattern to gentamicin, kanamycin, tobramycin
and ciprofloxacin (S1 Table).
Detection of PVL genes and bacterial-typing
PVL-encoding genes were detected in 27 (34%) of the 80 isolates obtained from 17 (27%) of
the 62 patients (anterior nares [n = 6] and wound [n = 12]) and 6 (21%) of the 29 HCWs. S.
aureus isolates from patients and HCWs were assigned 20 different spa-types and 16 STs
including four new STs: ST3248, ST3249, ST3250, ST3251 and one untypeable isolate (Table 3,
S1 Table). S. aureus with the spa-types t008, t084, t127, t2055, t304, t311, t5132, t645, t827,
t8453 (MSSA) and t928 (MRSA) were obtained from the nares of patients. S. aureus obtained
from wound swabs of patients belonged to spa-types t084, t311, t314, t355, t537, t645, and t939
(MSSA), and t008 and t928 (MRSA) (S1 Table). In the case of five patients, this may suggest
autoinoculation from the nares to wound or vice versa. The spa-types t127, t355, t861, t8860
(MSSA) and t928 (MRSA) were identified in S. aureus invasive infections. S. aureus carriage by
HCWs was identified as MSSA (t008, t024, t084, t127, t1816, t861 and t963) and MRSA (t928),
and most HCWs carried S. aureus with the same genotype on more than one occasion.
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Interestingly, 21 of the 22 MRSA isolates belonged to the spa-type t928 (ST250) while the other
MRSA isolate belonged to spa-type t008 (ST8). The MRSA isolates with spa-type t928 were cul-
tured from 11 patients and one HCW.
S. aureus invasive infection
S. aureus was detected in the blood cultures during the biweekly routine samplings in six (10%)
of the 62 patients hospitalized. On the first day of admission, 4 (6%) patients already had blood
cultures positive with S. aureus. Seven S. aureus isolates were obtained from the blood cultures
of the six patients. Three of these isolates were MRSA (t928), four were MSSA (t127, t355, t861
and t8860) and all 7 isolates were PVL-negative (S1 Table). Physicians received the results
including the antibiotic susceptibility pattern to treat patients for invasive infection. Patients
with MRSA invasive infection were treated by the attending physicians with either erythromy-
cin or vancomycin while patients with MSSA invasive infection were treated with erythromycin,
gentamicin or ciprofloxacin. However, the therapy was sometimes changed from vancomycin
to erythromycin, because patients could not afford vancomycin treatment.
In-hospital mortality
A mortality rate of 24% during the admission at the burn unit was recorded. Half of the
patients with a TBSA of 19% or more died during the admission (LD50 of 19%). Patients who
Table 2. Number of days of antibiotics prescribed per 100 days in the burn unit and antibiotic resistances of the 80 investigated S. aureus isolates.
Antibiotics Number of days of antibiotic used per 100 in-patient hospital days No. (resistance rate %)
Amoxicillin-clavulanic acid 1.9 -
Cefuroxime 60.6 -
Ceftazidime 1.6 -
Benzylpenicillin - 80 (100)
Oxacillin - 22 (28)
Vancomycin 0.4 0 (0)
Gentamicin 11.9 21 (26)
Tobramycin - 21 (26)
Kanamycin - 22 (28)
Ciprofloxacin 5.6 21 (26)
Levofloxacin 4.1 -
Chloramphenicol - 35 (44)
Clindamycin - 1 (1)
Erythromycin 2.3 1 (1)
Fosfomycin - 0 (0)
Fusidic acid - 0 (0)
Mupirocin - 0 (0)
Linezolid - 0 (0)
Teicoplanin - 0 (0)
Rifampicin - 1 (1)
Tetracycline - 41 (51)
Trimethoprim/sulfamethoxazole - 20 (25)
Metronidazole 2.9 -
Total 91.2
“-” indicates that antibiotics were not prescribed to burn patients or that the resistance of S. aureus to the respective antibiotics was not tested.
https://doi.org/10.1371/journal.pone.0181072.t002
S. aureus epidemiology in a burn unit in Ghana
PLOS ONE | https://doi.org/10.1371/journal.pone.0181072 July 13, 2017 6 / 12
died were in the hospital for a median of 9 days (IQR: 2–42). None of the patients with S.
aureus detected in the blood culture died (RR 0.23; 0.01–3.87). Mortality in patients with S.
aureus cultured at least once from wounds, blood or nares during the admission was 18.9%,
whereas mortality in patients without S. aureus cultured during their admission was 32% (RR
0.59; 0.25–1.42) (Table 4).
Discussion
The present study describes the S. aureus epidemiology in burn patients and HCWs in a burn
unit in Ghana. To our knowledge, this is the first report of such data from Ghana. In developed
countries, the elderly are often susceptible to burn injuries [25,26]. Our study describes a
much younger patient group with burns, which is consistent with reports from other health
Table 3. Antibiotic resistance profiles and detection of PVL genes in S. aureus isolates with different spa-types.
Spa-type ST No. of isolates Major antibiograms PVL-positive
t008 8, 2021 5 Ben 0
t024 8 1 Ben 0
t084 15, 3249, - 10 Ben, tri/sulf 7
t127 1, 3248 5 Ben 0
t1816 15 3 Ben, tri/sulf 2
t2055 2434 1 Ben, tet, chl, tri/sulf 0
t304 6 1 Ben 0
t311 5 2 Ben, tet, chl, rif, tri/sulf 0
t314 121 2 Ben, tet, tri/sulf 2
t355 152 8 Ben, chl 7
t5132 508 1 Ben 1
t537 3251 5 Ben, tet 3
t645 3250 4 Ben 4
t827 508 2 Ben, tri/sulf 0
t8453 508 1 Ben, tri/sulf 0
t861 508 3 Ben 0
t8860 45 1 Ben 0
t928 250 21 Ben, oxa, gen, kan, tob, cip, tet, chl 0
t939 45 1 Ben 0
t963 15 3 Ben 1
Ben- benzylpenicillin, oxa- oxacillin, gen- gentamicin, kan- kanamycin, tob- tobramycin, cip- ciprofloxacin, tet- tetracycline, chl- chloramphenicol, rif-
rifampicin, tri/sulf- Trimethoprim/sulfamethoxazole. The “-” indicates that an isolate was untypeable by MLST.
https://doi.org/10.1371/journal.pone.0181072.t003
Table 4. Carriage of or infection with S. aureus at least once during admission of patients.
S. aureus at least once (positive) No S. aureus p-value
Age (years) 26 25 0.57*
TBSA (median %) 15 16.5 0.83*
Sex: female (%) 18 (66%) 19 (54%) 0.32#
Mortality rate 5 (18.5%) 10 (28%) (RR 0.59; 0.25–1.42)
*, Mann-Whitney U Test used for analysis
#
, Pearson, chi-square used for analysis
RR, relative risk
https://doi.org/10.1371/journal.pone.0181072.t004
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centers in Ghana and other African countries, where children of 10 years and below represent
the majority of burn victims [4,10]. Most of the burn patients suffered from flame burns (39%)
due to the use of candles and kerosene lamps for lighting as a result of the national electricity
crisis in Ghana.
Referrals from the 20 hospitals and the ICU of the KBTH were often made due to the wors-
ening conditions of patients, lack of resources or skilled professionals for specialized care of
third degree burns, or logistical reasons. Routine screening of patients for MRSA carriage or
multi-drug resistant organisms (MDRO) are not performed in the burn unit. Here, infection
control measures were taken with regard to only one MRSA patient, which indicates the high
risk of patient-to-patient transmission events. Interestingly, the MRSA cases included patients
who tested positive on the day of admission and patients who acquired the MRSA during
admission. The majority of these isolates (21 of 22) were shown to belong to the spa-type t928
and ST250. Thus, patients that tested positive on admission could be the possible source of the
nosocomial MRSA transmission events. This observation highlights the need for implement-
ing infection control and prevention measures in referring health care centers to prevent out-
breaks of disease that currently remain unnoticed. Previous studies have shown that colonized
but non-isolated patients increase the risk for nosocomial transmission events [27,28]. Since
most presently identified MRSA cases were referrals, it is important that patients from referral
centers that frequently report MRSA, such as the KBTH ICU, be screened for MRSA when
transferred to the burn unit to prevent possible outbreaks. Further, almost half of the HCWs
(45%) were transient carriers of S. aureus, including MRSA, which indicates their possible
involvement in nosocomial transmission events in the burn unit. S. aureus carriage of 23%
among HCWs in other departments in this hospital has been reported [29]. In this respect, it
should be noted that bacterial typing methods, such as spa-typing and MLST, are not optimal
for inferring nosocomial events, because they have a relatively low discriminatory power com-
pared to whole genome sequencing. Therefore, whole genome sequencing analyses of the
MRSA isolates (ST250) will be needed to confirm such events.
The high incidence of MRSA isolates with ST250 is noteworthy. First reported as the cause
of epidemic MRSA disease and dominant MRSA genotype in the mid-1960s in Australia,
Europe (Denmark, Germany, Switzerland), Uganda and the United Kingdom, and during
the 1970s-1980s in Ireland [30–32], there are presently no reports of ST250-I MRSA in these
regions [31]. Recently, ST250-I MRSA has, however, emerged in skin and soft tissue infections
in a health care center in Ghana [14]. Further, our present data shows a wider distribution of
ST250-MRSA with the SCCmec type IV variant from other referral health care centers in
Ghana suggesting the rapid dissemination of this strain in hospitals of this country.
The overall use of antibiotics per 100 in-patient hospital days was observed to be high due
to the extended use of empirical treatment and lack of microbiological diagnostic results. Clin-
ical isolates obtained from burn patients have been reported to be resistant to commonly pre-
scribed drugs in burn units [33–35]. Thus, appropriate prescription of antibiotics is important
to prevent emergence of resistant bacteria. However, this can only be achieved if the burn
units are equipped with some baseline epidemiological and microbiological data.
We observed a 27% of carriage of PVL-positive S. aureus in burn patients. PVL-positive
MRSA was not detected in this study. PVL-positive MRSA has been reported in burn centers
in the United Kingdom (9%), United States of America (2.5%) and Iran (7%) [36–38]. Addi-
tionally, none of the S. aureus isolates from invasive infections carried the PVL gene. This is
remarkable as, more frequently, S. aureus isolates from invasive infections have been reported
to carry PVL-encoding genes in Ghana and the Democratic Republic of the Congo (49–75%)
[18,39]. Here, it should be mentioned that the major S. aureus spa-types t084, t355 and t928 as
identified in our study have been described previously in Ghana [14–18].
S. aureus epidemiology in a burn unit in Ghana
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The mortality rate (24%) recorded in our study was within the range (9–27%) reported by
burn centers in other sub-Saharan African countries [4]. We observed 100% mortality in
patients with TBSA burns greater than 40% [40,41]. The lethal Dose 50 (the percent TBSA at
which 50% of patient survive) is a measure of the quality of care given to burn patients. In the
present study, half of the patients with a TBSA of 19% died during the admission, indicating
that burns with such a relatively small size lead to poor clinical outcomes in Ghana. This con-
trasts with settings in more affluent countries, where therapeutic advancement in burn care
has increased the LD50 to 25–77% [25,42,43].
The lower mortality rate observed in patients carrying and/or infected with S. aureus was a
surprising finding. However, this may be explained by the accessibility of the microbiological
diagnostic results and timely and appropriate treatment of patients during the study period.
Further diagnostics on bacteria other than S. aureus were not performed. This lack of screen-
ing for microorganisms other than S. aureus that nonetheless are commonly involved in infec-
tious complications of burn wounds is a limitation to this study. Gram-negative bacteria such
as Pseudomonas aeruginosa and Acinetobacter baumannii have been reported to frequently
cause nosocomial infections in burn patients and may have antimicrobial resistance patterns
severely limiting the treatment options in this health care setting [44–47]. Of note, hospital
hygiene measures in the burn unit were not assessed in the present study. Previous studies
have reported low compliance of hand hygiene by health personnel [48–50] and high preva-
lence of pathogenic bacteria on surfaces of operating theaters, door handles, desktops and lava-
tories in health care settings in Ghana [51].
In conclusion, our study shows that it is very well possible that MRSA outbreaks occur
unnoticed in the presently investigated burn unit. This is highly worrisome as this burn unit is
representative for the situation in many sub-Saharan burn units. Although this has not become
directly evident from our study, improving the capacity for microbiological diagnostics and
antibiotic stewardship will most likely reduce the mortality rate in such burn units by opti-
mizing the use of antimicrobials and earlier detection of outbreaks of highly drug resistant
pathogens.
Supporting information
S1 Table. S. aureus isolates from burn patients and healthcare workers. “-” and empty cells
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